![]() |
市場調查報告書
商品編碼
2146828
畜牧業感染疾病物市場:全球市場預測,2026-2032年Anti-Infective Agents for Livestock Market - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,牲畜感染疾病物市場規模將成長至 90.3 億美元,年複合成長率為 10.00%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 46.3億美元 |
| 預計年份:2026年 | 50.3億美元 |
| 預測年份 2032 | 90.3億美元 |
| 複合年成長率 (%) | 10.00% |
畜牧業抗感染疾病劑包括用於預防、控制或治療影響肉類用動物的細菌性、病毒性、真菌性和寄生蟲性疾病的產品。此領域涵蓋動物用藥品、生技藥品以及相關的給藥和診斷方法。其發展受動物健康狀況、食品安全、抗菌素抗藥性、獸醫監管、生產系統設計和法規要求的影響。需求因地區和生產系統而異,取決於目標動物種類、疾病負擔、畜牧管理實踐以及獲得專業服務的途徑。
目前的趨勢是從常規的、廣泛的預防性治療轉向更有針對性的疾病管理。生產者和獸醫越來越重視疫苗接種、生物安全、診斷、隔離、衛生、營養和農場層面的監測,然後再考慮使用抗感染藥物。監管機構對合理使用抗生素的關注也促進了負責任的處方、治療記錄的保存、遵守停藥期,以及在存在合適的替代方案時減少對具有重要醫學價值的抗生素的依賴。
人工智慧 (AI) 可透過識別農場記錄中的異常活動、動物行為、採食量、體溫、生長、死亡率和生產性能等信息,輔助畜牧業感染控制。這些工具有助於及早發現潛在疫情,並優先識別需要獸醫評估的動物或畜群。結合檢驗的診斷測試,人工智慧有助於更準確地選擇治療方案,並減少不必要的抗感染劑暴露。
在北美,完善的獸醫基礎設施與對處方管理、食品安全和合理使用抗生素的高度重視相結合。在拉丁美洲,多樣化的生產體系和出口導向策略使得生物安全、殘留限量合規、獸醫服務可及性和疾病監測尤為重要。在歐洲,人們高度重視謹慎使用抗生素、動物福利、可追溯性以及跨市場監管實施的協調。
東協合作涉及跨境動物流動、食品生產、區域疾病監測和獸醫實踐的協調,但其具體實施方式在各成員國之間有所不同。金磚國家涵蓋了主要的畜牧業和消費經濟體,這些經濟體的監管體系、生產結構和疾病控制能力各不相同,而合作有助於加強監測、研究以及獲取品質有保證的獸藥。
面向澳洲和紐西蘭的生產實踐強調以牧場為基礎的系統、生物安全以及分散的獸醫服務。在澳大利亞,對分散在各地的業務場所進行監控也是一項優先事項。在巴西的大規模畜牧業中,疾病預防、出口合規、可追溯性和合理使用抗生素是核心考量。在加拿大和美國,先進的診斷技術和獸醫服務,以及對合理使用抗生素和治療記錄的加強監控,正受到重視。
產業領導者應使其產品、服務和管理策略與獸醫的決策一致,而非以治療量為導向。優先行動包括:推廣檢驗的診斷方法、支持疫苗接種和生物安全計畫、提高產品品質和供應穩定性,以及製定清晰的停藥間隔和劑量指南。與獸醫、生產商、實驗室、監管機構和生產商組織夥伴關係,可以加速這些措施的推廣,並加強來自第一線的回饋。
本執行摘要採結構化、質性、綜合分析方法,針對畜牧業抗感染藥物領域進行研究。評估架構涵蓋疾病預防和治療措施、抗菌藥物的合理使用、獸醫法規、食品安全要求、生物安全、診斷、生產系統特徵、供應鏈狀況以及數位技術的角色。區域、群體和國家層面的具體考量是基於管治、畜牧生產、獸醫能力和疾病控制重點方面的既有差異。
目前畜牧業抗感染劑的發展趨勢日益體現在預防、精準、合理使用和抗逆性等。有效的方案應結合適當的飼養管理、生物安全措施、疫苗接種、快速診斷、適當的獸醫治療以及嚴格遵守停藥期和食品安全要求。由於地區和國家間的差異,並不存在適用於所有生產系統的單一操作模式。
The Anti-Infective Agents for Livestock Market is projected to grow by USD 9.03 billion at a CAGR of 10.00% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 4.63 billion |
| Estimated Year [2026] | USD 5.03 billion |
| Forecast Year [2032] | USD 9.03 billion |
| CAGR (%) | 10.00% |
Anti-infective agents for livestock include products used to prevent, control, or treat bacterial, viral, fungal, and parasitic diseases affecting food-producing animals. The field encompasses veterinary medicines, biologics, and related delivery and diagnostic practices. Its development is shaped by animal-health outcomes, food safety, antimicrobial resistance, veterinary oversight, production-system design, and regulatory requirements. Demand conditions vary by species, disease burden, husbandry practices, and access to professional services across regions and production systems.
The landscape is shifting from routine, broad preventive treatment toward more targeted disease management. Producers and veterinarians increasingly emphasize vaccination, biosecurity, diagnostics, isolation, hygiene, nutrition, and farm-level surveillance before selecting anti-infective interventions. Regulatory attention to antimicrobial stewardship is also encouraging responsible prescribing, treatment records, withdrawal compliance, and reduced reliance on medically important antimicrobials where alternatives are appropriate.
Supply-chain resilience has become a parallel priority. Manufacturing quality, product availability, cold-chain performance for temperature-sensitive products, and reliable veterinary distribution influence treatment continuity. Digital recordkeeping and integrated herd-health programs are improving traceability, while changing climate conditions, animal movement, and intensified production can alter exposure patterns and increase the need for rapid detection and response.
Artificial intelligence can support livestock anti-infective management by identifying abnormal activity in farm records, animal behavior, feed intake, temperature, growth, mortality, and production performance. These tools may help flag potential outbreaks earlier and prioritize animals or groups for veterinary assessment. When combined with validated diagnostic tests, AI can contribute to more precise treatment selection and reduce unnecessary exposure to anti-infective agents.
Implementation requires representative training data, transparent validation, cybersecurity, interoperability with farm-management systems, and clear accountability for clinical decisions. AI should assist-not replace-veterinarians and established stewardship protocols. Bias caused by differences in species, breeds, housing systems, geography, and data quality can produce unreliable alerts, making local validation and continuous monitoring essential.
North America combines sophisticated veterinary infrastructure with strong attention to prescription controls, food safety, and antimicrobial stewardship. Latin America's varied production systems and export orientation make biosecurity, residue compliance, veterinary access, and disease surveillance especially important. Europe places substantial emphasis on prudent antimicrobial use, animal welfare, traceability, and coordinated regulatory implementation across markets.
The Middle East faces uneven access to veterinary services, climatic stress, and dependence on resilient supply and cold-chain systems. Africa's priorities include strengthening diagnostics, surveillance, extension services, and access to quality-assured products across fragmented production environments. Asia-Pacific spans highly diverse livestock systems, from smallholder operations to intensive commercial production, increasing the value of scalable vaccination, affordable diagnostics, responsible prescribing, and region-specific outbreak preparedness.
ASEAN cooperation is relevant to cross-border animal movement, food production, regional disease surveillance, and harmonization of veterinary practices, although implementation varies among members. BRICS countries encompass major livestock-producing and consuming economies with differing regulatory systems, production structures, and disease-control capabilities; collaboration can support surveillance, research, and access to quality-assured veterinary products.
The European Union emphasizes coordinated rules, antimicrobial stewardship, traceability, and harmonized food-safety objectives. G7 members generally combine advanced veterinary capacity with strong monitoring and regulatory expectations. GCC countries place particular importance on food-security resilience, import controls, and supply reliability. NATO members are relevant to broader biosecurity and resilience discussions, while livestock-health governance remains primarily a national and civilian responsibility.
Australia and New Zealand-oriented production practices emphasize extensive systems, biosecurity, and distance-sensitive veterinary access; Australia also prioritizes surveillance across geographically dispersed operations. Brazil's large livestock sector makes disease prevention, export compliance, traceability, and responsible antimicrobial use central considerations. Canada and the United States combine advanced diagnostics and veterinary services with increasing scrutiny of antimicrobial stewardship and treatment documentation.
China and India have diverse production structures and substantial smallholder participation alongside intensive systems, creating strong needs for scalable surveillance, vaccination, diagnostics, and practitioner access. Japan and South Korea emphasize high-quality production, biosecurity, and strict food-safety controls. Mexico's priorities include veterinary access, disease monitoring, and trade-related compliance. France, Germany, Italy, Spain, and the United Kingdom focus on prudent use, traceability, animal welfare, residue control, and integrated farm-health management. Russia's large and varied production base places emphasis on domestic supply resilience, veterinary oversight, and disease-control capacity.
Industry leaders should align product, service, and stewardship strategies with veterinary decision-making rather than treatment volume. Priority actions include expanding validated diagnostics, supporting vaccination and biosecurity programs, improving product quality and supply continuity, and designing clear withdrawal and administration guidance. Partnerships with veterinarians, producers, laboratories, regulators, and producer organizations can improve adoption and strengthen field feedback.
Organizations should also establish measurable stewardship indicators, audit treatment records, monitor resistance and adverse events, and invest in workforce training. Digital tools and AI should be deployed where they solve a defined operational problem, with human oversight, data governance, and local validation. Regional adaptation is essential: solutions should reflect species, production scale, climate, infrastructure, regulatory requirements, and the availability of veterinary services.
This executive summary uses a structured qualitative synthesis of the livestock anti-infective field. The assessment framework considers disease prevention and treatment practices, antimicrobial stewardship, veterinary regulation, food-safety requirements, biosecurity, diagnostics, production-system characteristics, supply-chain conditions, and the role of digital technologies. Regional, group, and country discussions are organized around documented differences in governance, livestock production, veterinary capacity, and disease-control priorities.
Insights should be validated against current official veterinary regulations, national disease-surveillance reports, peer-reviewed scientific literature, recognized animal-health guidance, and verified producer or veterinary records. Because policies, disease conditions, and product authorizations change over time, country-level decisions require jurisdiction-specific review and consultation with qualified veterinary professionals.
The anti-infective agents for livestock landscape is increasingly defined by prevention, precision, stewardship, and resilience. Effective programs combine sound husbandry, biosecurity, vaccination, rapid diagnosis, appropriate veterinary treatment, and reliable compliance with withdrawal and food-safety requirements. Regional and national differences mean that no single operating model is suitable for every production system.
Leaders that integrate clinical expertise with high-quality data, responsible product use, and dependable supply practices can strengthen animal health while addressing antimicrobial-resistance concerns. The most durable approach is a coordinated one in which producers, veterinarians, regulators, laboratories, and technology providers share responsibility for timely, evidence-based disease management.